Statistics for QIAGEN NV (id:8873 QGEN)

Valuation metrics

Market cap

9.11B

Enterprise value

9.71B

Trailing P/E (ttm)

91.09

Forward P/E

17.90

PEG ratio

17.90

Price/Sales (ttm)

4.63

Price/Book (mrq)

2.58

Enterprise Value/Revenue

4.94

Enterprise Value/EBITDA

14.50

Overview

Shares outstanding

222.26M

Float

220.33M

Shares short

3.57M

% Held by insiders

0.02%

% Held by institutions

0.88%

Average volume (10 days)

1.02M

Average volume (90 days)

Price summary

52-Week low

39.03

52-Week high

47.44

52-Week change

2.85%

Beta

0.40

50-Day moving average

43.85

200-Day moving average

43.45

Dividends and splits

Forward annual dividend rate

5.28

Forward annual dividend yield

0.13

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

January 30th, 2024

Ex-dividend date

January 30th, 2024

Last split factor

2:1

Last split date

January 25th, 2017

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

4.73%

Operating margin

25.79%

Operational effectiveness

Return on assets

4.84%

Return on equity

2.57%

Income statement

Revenue (ttm)

8.84

Revenue per share (ttm)

8.84

Quarterly revenue growth (yoy)

0.26

Gross profit (ttm)

1.23B

EBITDA

723.86M

Net income to common (ttm)

92.93M

Diluted EPS (ttm)

0.45

Quarterly earnings growth (yoy)

26.00%

Balance sheet

Total cash (mrq)

1.48B

Total cash per share (mrq)

6.66

Total debt (mrq)

2.01B

Total Debt/Equity (mrq)

57.02

Current ratio (mrq)

217.50%

Book value per share (mrq)

15.88

Cash flow

Cash flow statement

633.41M

Levered free cash flow (LFCF)

396.84M